# Pilot Trial of Transnasal Nicotine in Parkinson Disease

> **NCT03865121** · PHASE2 · COMPLETED · sponsor: **El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez** · enrollment: 6 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Nicotine Nasal Spray 10 MG/ML (0.5 MG/SPRAY)

## Key facts

- **NCT ID:** NCT03865121
- **Lead sponsor:** El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-04
- **Primary completion:** 2019-11-02
- **Final completion:** 2019-11-02
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2019-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03865121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03865121, "Pilot Trial of Transnasal Nicotine in Parkinson Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03865121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*